
Bupropion Hydrochloride
300 mg/1 · Extended-Release Tablet
By Upsher-Smith Laboratories, LLC
- NDC
- 24979-102
- Route
- Oral
- Therapeutic class
- Aminoketone , Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-06)NDC 24979-102-06Available to order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-07)NDC 24979-102-07Available to order
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-02)NDC 24979-102-02Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

